Roflumilast reduces allergen-induced airway inflammation in patients with asthma – Healio

Roflumilast reduces allergen-induced airway inflammation in patients with asthma
Healio
“The studies presented here show that roflumilast has no acute bronchodilator actions in patients with mild to moderate asthma,” Philip Bardin, PhD, the director of the lung and sleep unit at Monash Health in Australia, and colleagues wrote. “This

View full post on asthma – Google News

Asthma patients don’t understand preventer inhalers or forget to use them – Daily Mail


Daily Mail

Asthma patients don't understand preventer inhalers or forget to use them
Daily Mail
'Reliever inhalers provide immediate relief so they're popular with patients because they feel better straight away. 'People commonly neglect their preventer once symptoms improve and that can mean they aren't getting proper treatment.' This was the
Back to School With AsthmaU.S. News & World Report

all 3 news articles »

View full post on asthma – Google News

Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada – Lung Disease News


Lung Disease News

Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada
Lung Disease News
GlaxoSmithKline (GSK) and VIBATIV® (telavancin) developer Theravance Biopharma, have just been granted Canadian approval for Breo Ellipta, a once-a-day maintenance treatment for asthma in patients who are at least 18 years old and have reversible …

and more »

View full post on asthma – Google News